StoneX Group Inc. trimmed its stake in GMO U.S. Value ETF (NYSEARCA:GMOV – Free Report) by 40.2% during the third quarter, HoldingsChannel.com reports. The fund owned 72,988 shares of the company’s stock after selling 49,161 shares during the period. StoneX Group Inc.’s holdings in GMO U.S. Value ETF were worth $2,315,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Fifth Third Bancorp purchased a new stake in shares of GMO U.S. Value ETF during the first quarter valued at $84,000. Pathway Financial Advisors LLC acquired a new position in shares of GMO U.S. Value ETF in the 2nd quarter valued at $246,000. Finally, Essential Partners LLC increased its stake in GMO U.S. Value ETF by 8.6% in the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after purchasing an additional 4,774 shares in the last quarter.
GMO U.S. Value ETF Stock Performance
Shares of GMOV opened at $32.70 on Monday. The business’s 50-day moving average price is $32.58 and its 200 day moving average price is $30.52. The stock has a market capitalization of $98.10 million, a P/E ratio of 12.08 and a beta of 0.61. GMO U.S. Value ETF has a 1-year low of $25.92 and a 1-year high of $34.16.
GMO U.S. Value ETF Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Wednesday, September 30th were issued a $0.1678 dividend. The ex-dividend date was Wednesday, September 30th. This is a positive change from GMO U.S. Value ETF’s previous quarterly dividend of $0.1283. This represents a $0.67 annualized dividend and a dividend yield of 2.1%.
GMO U.S. Value ETF Company Profile
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Further Reading
- Five stocks we like better than GMO U.S. Value ETF
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Want to see what other hedge funds are holding GMOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Value ETF (NYSEARCA:GMOV – Free Report).
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
